Pacira BioSciences, Inc. Net Income 2009–2025
Pacira BioSciences, Inc. reported $7.03M of net income for fiscal 2025. That was 107.1% higher than fiscal 2024. Compared with fiscal 2020, the change was -95.2%.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $7.03M | 1.0% | +107.1% |
| FY 2024 | $-99.56M | -14.2% | -337.3% |
| FY 2023 | $41.95M | 6.2% | +163.7% |
| FY 2022 | $15.91M | 2.4% | -62.1% |
| FY 2021 | $41.98M | 7.8% | -71.2% |
| FY 2020 | $145.52M | 33.9% | +1421.0% |
| FY 2019 | $-11.02M | -2.6% | -2238.9% |
| FY 2018 | $-471,000 | -0.1% | +98.9% |
| FY 2017 | $-42.61M | -14.9% | -12.3% |
| FY 2016 | $-37.95M | -13.7% | -2144.7% |
| FY 2015 | $1.86M | 0.7% | +113.5% |
| FY 2014 | $-13.72M | -6.9% | +78.5% |
| FY 2013 | $-63.91M | -74.7% | -22.2% |
| FY 2012 | $-52.28M | -133.8% | -20.7% |
| FY 2011 | $-43.33M | -276.2% | -59.6% |
| FY 2010 | $-27.15M | -186.4% | +14.4% |
| FY 2009 | $-31.71M | -211.3% | — |
Source: Pacira BioSciences, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open PCRX 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Pacira BioSciences, Inc. reported $7.03M of net income for fiscal 2025. That was 107.1% higher than fiscal 2024. Compared with fiscal 2020, the change was -95.2%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Pacira BioSciences, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freePacira BioSciences, Inc. — frequently asked questions
What is Pacira BioSciences, Inc.'s net income?
Pacira BioSciences, Inc. (PCRX) reported net income of $7.03M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Pacira BioSciences, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.